Degradation of NF-κB in T Cells by Gangliosides Expressed on Renal Cell Carcinomas

Journal of Immunology

Volumn 172, Issue 6, 2004, Pages 3480-3490

  Thornton, Mark V ^a   Kudo, Daisuke ^a,b   Rayman, Patricia ^a   Horton, Claudine ^a   Molto, Luis ^a,c   Cathcart, Martha K ^a   Ng, Christopher ^a   Paszkiewicz Kozik, Ewa ^a,d   Bukowski, Ronald ^a   Derweesh, Ithaar ^a   Tannenbaum, Charles S ^a   Finke, James H ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b HIROSAKI UNIVERSITY   (Japan)

^c HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^d INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

1 PHENYL 2 HEXADECANOYLAMINO 3 PYRROLIDINO 1 PROPANOL; CASPASE; CASPASE INHIBITOR; CERAMIDE GLUCOSYLTRANSFERASE INHIBITOR; GANGLIOSIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN P50; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER IMMUNOTHERAPY; CELL PROTECTION; COCULTURE; ENZYME ACTIVATION; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; LEUKEMIA CELL LINE; MITOCHONDRION; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SYNTHESIS; T LYMPHOCYTE; TRANSGENE; TUMOR ASSOCIATED LEUKOCYTE;

EID: 12144290522     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.6.3480     Document Type: Article

References (64)

1. Bours, V., M. Bentires-Alj, A. C. Hellin, P. Viatour, P. Robe, S. Delhalle, V. Benoit, and M. P. Merville. 2000. Nuclear factor-κB, cancer, and apoptosis. Biochem. Pharmacol. 60:1085.
2. Siebenlist, U. 1997. NF/IκB proteins: their role in cell growth, differentiation and development. Madrid, Spain, July 7-10, 1996. Biochim. Biophys. Acta 1332:R7.
3. Wulczyn, F. G., D. Krappmann, and C. Scheidereit. 1996. The NF-κB/Rel and IκB gene families: mediators of immune response and inflammation. J. Mol. Med. 74:749.
4. Rushlow, C., and R. Warrior. 1992. The rel family of proteins. Bioessays 14:89.
5. Baldwin, A. S., Jr. 1996. The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol. 14:649.
6. Whiteside, S. T., and A. Israel. 1997. IκB proteins: structure, function and regulation. Semin. Cancer Biol. 8:75.
7. Schmitz, M. L., and P. A. Baeuerle. 1995. Multi-step activation of NF-κB/Rel transcription factors. Immunobiology 193:116.
8. Alcamo, E., J. P. Mizgerd, B. H. Horwitz, R. Bronson, A. A. Beg, M. Scott, C. M. Doerschuk, R. O. Hynes, and D. Baltimore. 2001. Targeted mutation of TNF receptor I rescues the RelA-deficient mouse and reveals a critical role for NF-κB in leukocyte recruitment. J. Immunol. 167:1592.
9. DiDonato, J. A., M. Hayakawa, D. M. Rothwarf, E. Zandi, and M. Karin. 1997. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature 388:548.
10. Jeremias, I., C. Kupatt, B. Baumann, I. Herr, T. Wirth, and K. M. Debatin. 1998. Inhibition of nuclear factor κB activation attenuates apoptosis resistance in lymphoid cells. Blood 91:4624.
11. Kabouridis, P. S., M. Hasan, J. Newson, D. W. Gilroy, and T. Lawrence. 2002. Inhibition of NF-κB activity by a membrane-transducing mutant of IκBα. J. Immunol. 169:2587.
12. Buggins, A. G., D. Milojkovic, M. J. Arno, N. C. Lea, G. J. Mufti, N. S. Thomas, and W. J. Hirst. 2001. Microenvironment produced by acute myeloid leukemia cells prevents T cell activation and proliferation by inhibition of NF-∴B, c-Myc, and pRb pathways. J. Immunol. 167:6021.
13. Correa, M. R., A. C. Ochoa, P. Ghosh, H. Mizoguchi, L. Harvey, and D. L. Longo. 1997. Sequential development of structural and functional alterations in T cells from tumor-bearing mice. J. Immunol. 158:5292.
14. Ghosh, P., A. Sica, H. A. Young, J. Ye, J. L. Franco, R. H. Wiltrout, D. L. Longo, N. R. Rice, and K. L. Komschlies. 1994. Alterations in NFκB/Rel family proteins in splenic T-cells from tumor-bearing mice and reversal following therapy. Cancer Res. 54:2969.
15. Kim, H. J., J. K. Park, and Y. G. Kim. 1999. Suppression of NF-κB activation in normal T cells by supernatant fluid from human renal cell carcinomas. J. Korean Med. Sci. 14:299.
16. Li, X., J. Liu, J. K. Park, T. A. Hamilton, P. Rayman, E. Klein, M. Edinger, R. Tubbs, R. Bukowski, and J. H. Finke. 1994. T cells from renal cell carcinoma patients exhibit an abnormal pattern of κB-specific DNA-binding activity: a preliminary report. Cancer Res. 54:5424.
17. Uzzo, R. G., P. Rayman, V. Kolenko, P. E. Clark, T. Bloom, A. M. Ward, L. Molto, C. Tannenbaum, L. J. Worford, R. Bukowski, et al. 1999. Mechanisms of apoptosis in T cells from patients with renal cell carcinoma. Clin. Cancer Res. 5:1219.
18. Finke, J. H., P. Rayman, R. George, C. S. Tannenbaum, V. Kolenko, R. Uzzo, A. C. Novick, and R. M. Bukowski. 2001. Tumor-induced sensitivity to apoptosis in T cells from patients with renal cell carcinoma: role of nuclear factor-κB suppression. Clin. Cancer Res. 7:940s.
19. Uzzo, R. G., P. Rayman, V. Kolenko, P. E. Clark, M. K. Cathcart, T. Bloom, A. C. Novick, R. M. Bukowski, T. Hamilton, and J. H. Finke. 1999. Renal cell carcinoma-derived gangliosides suppress nuclear factor-κB activation in T cells. J. Clin. Invest. 104:769.
20. Bukowski, R. M., P. Rayman, R. Uzzo, T. Bloom, K. Sandstrom, D. Peereboom, T. Olencki, G. T. Budd, D. McLain, P. Elson, et al. 1998. Signal transduction abnormalities in T lymphocytes from patients with advanced renal carcinoma: clinical relevance and effects of cytokine therapy. Clin. Cancer Res. 4:2337.
21. Kolenko, V., T. Bloom, P. Rayman, R. Bukowski, E. Hsi, and J. H. Finke. 1999. Inhibition of NF-κB activity in human T lymphocytes induces caspase-dependent apoptosis without detectable activation of caspase-1 and -3. J. Immunol. 163:590.
22. Deng, W., R. Li, and S. Ladisch. 2000. Influence of cellular ganglioside depletion on tumor formation. J. Natl. Cancer Inst. 92:912.
23. Kudo, D., P. Rayman, C. Horton, M. K. Cathcart, R. M. Bukowski, M. Thornton, C. Tannenbaum, and J. H. Finke. 2003. Gangliosides expressed by the renal cell carcinoma cell line SK-RC-45 are involved in tumor-induced apoptosis of T cells. Cancer Res. 63:1676.
24. Gross, A. 2001. BCL-2 proteins: regulators of the mitochondrial apoptotic program. IUBMB Life 52:231.
25. Shimizu, S., M. Narita, and Y. Tsujimoto. 1999. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 399:483.
26. Molto, L., P. Rayman, E. Paszkiewicz-Kozik, M. Thornton, L. Reese, J. C. Thomas, T. Das, D. Kudo, R. Bukowski, J. H. Finke, and C. Tannenbaum. 2003. The Bcl-2 transgene protects T cells from renal cell carcinoma-mediated apoptosis. Clin. Cancer Res. 9:4060.
27. Olshefski, R., and S. Ladisch. 1998. Synthesis, shedding, and intercellular transfer of human medulloblastoma gangliosides: abrogation by a new inhibitor of glucosylceramide synthase. J. Neurochem. 70:467.
28. Sorice, M., I. Parolini, T. Sansolini, T. Garofalo, V. Dolo, M. Sargiacomo, T. Tai, C. Peschle, M. R. Torrisi, and A. Pavan. 1997. Evidence for the existence of ganglioside-enriched plasma membrane domains in human peripheral lymphocytes. J. Lipid Res. 38:969.
29. Li, R., J. Manela, Y. Kong, and S. Ladisch. 2000. Cellular gangliosides promote growth factor-induced proliferation of fibroblasts. J. Biol. Chem. 275:34213.
30. Sun, P., X. Q. Wang, K. Lopatka, S. Bangash, and A. S. Paller. 2002. Ganglioside loss promotes survival primarily by activating integrin-linked kinase/Akt without phosphoinositide 3-OH kinase signaling. J. Invest. Dermatol. 119:107.
31. Yates, A. J., and A. Rampersaud. 1998. Sphingolipids as receptor modulators: an overview. Ann. NY Acad. Sci. 845:57.
32. Black, P. H. 1980. Shedding from the cell surface of normal and cancer cells. Adv. Cancer Res. 32:75.
33. Ladisch, S., B. Gillard, C. Wong, and L. Ulsh. 1983. Shedding and immunoregulatory activity of YAC-1 lymphoma cell gangliosides. Cancer Res. 43:3808.
34. Ritter, G., and P. O. Livingston. 1991. Ganglioside antigens expressed by human cancer cells. Semin. Cancer Biol. 2:401.
35. Hoon, D. S., E. Okun, H. Neuwirth, D. L. Morton, and R. F. Irie. 1993. Aberrant expression of gangliosides in human renal cell carcinomas. J. Urol. 150:2013.
36. Valentino, L., T. Moss, E. Olson, H. J. Wang, R. Elashoff, and S. Ladisch. 1990. Shed tumor gangliosides and progression of human neuroblastoma. Blood 75:1564.
37. McKallip, R., R. Li, and S. Ladisch. 1999. Tumor gangliosides inhibit the tumor-specific immune response. J. Immunol. 163:3718.
38. Ito, A., S. B. Levery, S. Saito, M. Satoh, and S. Hakomori. 2001. A novel ganglioside isolated from renal cell carcinoma. J. Biol. Chem. 276:16695.
39. Irani, D. N., K. I. Lin, and D. E. Griffin. 1996. Brain-derived gangliosides regulate the cytokine production and proliferation of activated T cells. J. Immunol. 157:4333.
40. Irani, D. N. 1998. Brain-derived gangliosides induce cell cycle arrest in a murine T cell line. J. Neuroimmunol. 87:11.
41. Kong, Y., R. Li, and S. Ladisch. 1998. Natural forms of shed tumor gangliosides. Biochim. Biophys. Acta 1394:43.
42. Ladisch, S., R. Li, and E. Olson. 1994. Ceramide structure predicts tumor ganglioside immunosuppressive activity. Proc. Natl. Acad. Sci. USA 91:1974.
43. Li, R., N. Villacreses, and S. Ladisch. 1995. Human tumor gangliosides inhibit murine immune responses in vivo. Cancer Res. 55:211.
44. Shurin, G. V., M. R. Shurin, S. Bykovskaia, J. Shogan, M. T. Lotze, and E. M. Barksdale, Jr. 2001. Neuroblastoma-derived gangliosides inhibit dendritic cell generation and function. Cancer Res. 61:363.
45. Colell, A., C. Garcia-Ruiz, J. Roman, A. Ballesta, and J. C. Fernandez-Checa. 2001. Ganglioside GD3 enhances apoptosis by suppressing the nuclear factor-κB-dependent survival pathway. FASEB J. 15:1068.
46. Kang, K. H., K. H. Lee, M. Y. Kim, and K. H. Choi. 2001. Caspase-3-mediated cleavage of the NF-κB subunit p65 at the NH2 terminus potentiates naphthoquinone analog-induced apoptosis. J. Biol. Chem. 276:24638.
47. Ravi, R., A. Bedi, E. J. Fuchs, and A. Bedi. 1998. CD95 (Fas)-induced caspase-mediated proteolysis of NF-κB. Cancer Res. 58:882.
48. Levkau, B., M. Scatena, C. M. Giachelli, R. Ross, and E. W. Raines. 1999. Apoptosis overrides survival signals through a caspase-mediated dominant-negative NF-κB loop. Nat. Cell Biol. 1:227.
49. You, Z., L. V. Madrid, D. Saims, J. Sedivy, and C.-Y. Wang. 2002. c-Myc sensitizes cells to TNF-mediated apoptosis by inhibiting NF-κB transactivation. J. Biol. Chem. 277:36671.
50. Scaffidi, C., S. Fulda, A. Srinivasan, C. Friesen, F. Li, K. J. Tomaselli, K. M. Debatin, P. H. Krammer, and M. E. Peter. 1998. Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 17:1675.
51. Scaffidi, C., I. Schmitz, J. Zha, S. J. Korsmeyer, P. H. Krammer, and M. E. Peter. 1999. Differential modulation of apoptosis sensitivity in CD95 type I and type II cells. J. Biol. Chem. 274:22532.
52. Korsmeyer, S. J., M. C. Wei, M. Saito, S. Weiler, K. J. Oh, and P. H. Schlesinger. 2000. Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c. Cell Death Differ. 7:1166.
53. Roucou, X., S. Montessuit, B. Antonsson, and J. C. Martinou. 2002. Bax oligomerization in mitochondrial membranes requires tBid (caspase-8-cleaved Bid) and a mitochondrial protein. Biochem. J. 368:915.
54. Shiozaki, E. N., J. Chai, and Y. Shi. 2002. Oligomerization and activation of caspase-9, induced by Apaf-1 CARD. Proc. Natl. Acad. Sci. USA 99:4197.
55. Srinivasula, S. M., M. Ahmad, T. Fernandes-Alnemri, and E. S. Alnemri. 1998. Autoactivation of procaspase-9 by Apaf-l-mediated oligomerization. Mol. Cell 1:949.
56. Debatin, K. M., D. Poncet, and G. Kroemer. 2002. Chemotherapy: targeting the mitochondrial cell death pathway. Oncogene 21:8786.
57. Maestre, I., J. Jordan, S. Calvo, J. A. Reig, V. Cena, B. Soria, M. Prentki, and E. Roche. 2003. Mitochondrial dysfunction is involved in apoptosis induced by serum withdrawal and fatty acids in the β-cell line INS-1. Endocrinology 144:335.
58. Matsko, C. M., O. C. Hunter, H. Rabinowich, M. T. Lotze, and A. A. Amoscato. 2001. Mitochondrial lipid alterations during Fas- and radiation-induced apoptosis. Biochem. Biophys. Res. Commun. 287:1112.
59. Adachi, S., A. R. Cross, B. M. Babior, and R. A. Gottlieb. 1997. Bcl-2 and the outer mitochondrial membrane in the inactivation of cytochrome c during Fas-mediated apoptosis. J. Biol. Chem. 272:21878.
60. Harris, M. H., and C. B. Thompson. 2000. The role of the Bcl-2 family in the regulation of outer mitochondrial membrane permeability. Cell Death Differ. 7:1182.
61. Reed, J. C., J. M. Jurgensmeier, and S. Matsuyama. 1998. Bcl-2 family proteins and mitochondria. Biochim. Biophys. Acta 1366:127.
62. Baeuerle, P. A., and T. Henkel. 1994. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12:141.
63. Gerondakis, S., R. Grumont, I. Rourke, and M. Grossmann. 1998. The regulation and roles of Rel/NF-κB transcription factors during lymphocyte activation. Curr. Opin. Immunol. 10:353.
64. Ghosh, S., M. J. May, and E. B. Kopp. 1998. NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16:225.